泰格医药(300347)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

300347 泰格医药

已收盘 04-30 15:00:00

{"stockData":{"symbol":"300347","market":"SZ","secType":"STK","nameCN":"泰格医药","latestPrice":59.11,"timestamp":1714460589000,"preClose":59.67,"halted":0,"volume":10940133,"delay":0,"floatShares":578000000,"shares":872000000,"eps":1.9389,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.56,"latestTime":"04-30 15:00:00","open":59,"high":60.21,"low":58.4,"amount":650000000,"amplitude":0.0303,"askPrice":59.15,"askSize":5,"bidPrice":59.11,"bidSize":18,"shortable":0,"etf":0,"ttmEps":1.9389,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":59.67,"symbolType":"stock","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":65.64,"lowLimit":53.7,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":872418220,"pbRate":2.46,"roa":"--","roe":"1.12%","epsLYR":2.34,"committee":-0.574074,"marketValue":51569000000,"floatMarketCap":34142000000,"peRate":30.486358,"changeRate":-0.0094,"turnoverRate":0.0189,"status":1},"requestUrl":"/m/hq/s/300347","defaultTab":"news","newsList":[{"id":"2432153504","title":"泰格医药(03347.HK)计划回购A股  资金上限10亿人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2432153504","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2432153504?lang=zh_cn&edition=full","pubTime":"2024-05-01 23:19","pubTimestamp":1714576740,"startTime":"0","endTime":"0","summary":"泰格医药(03347.HK) 公布，计划以自有资金或自筹资金回购部分A股，资金总额不低于5亿人民币且不超过10亿人民币；回购价格不超过72元人民币。按上限测算，预计回购股数不低于1,388万股，占总股本1.59%。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-30 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20210301160530229_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20210301160530229_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1346666/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2431322299","title":"泰格医药(03347)拟斥资5亿-10亿元回购不低于1388.89万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431322299","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431322299?lang=zh_cn&edition=full","pubTime":"2024-04-30 22:26","pubTimestamp":1714487218,"startTime":"0","endTime":"0","summary":"按照回购金额上限10亿元(含)测算，预计回购股份数量不低于1388.89万股，占公司当前总股本的1.59%，占公司当前A股总股本的1.85%;按照回购金额下限5亿元测算，预计回购股份数量不低于694.44万股，占公司当前总股本的0.80%，占公司当前A股总股本的0.93%。具体回购股份数量以回购期满时实际回购的股份数量为准。本次回购股份实施期限为自股东大会审议通过回购股份方案之日起12个月内。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1116580.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431393473","title":"泰格医药(03347)将于7月31日派发末期股息10股5.68元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431393473","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2431393473?lang=zh_cn&edition=full","pubTime":"2024-04-30 16:47","pubTimestamp":1714466843,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药(03347)发布公告，该公司将于2024年7月31日派发末期股息10股5.68元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1116234.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2431234120","title":"泰格医药(03347)上涨5.06%，报35.3元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2431234120","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2431234120?lang=zh_cn&edition=full","pubTime":"2024-04-29 10:41","pubTimestamp":1714358486,"startTime":"0","endTime":"0","summary":"4月29日，泰格医药(03347)盘中上涨5.06%，截至10:41，报35.3元/股，成交4073.8万元。杭州泰格医药科技股份有限公司是一家提供全周期生物医药研发服务的公司，主要为全球制药和医疗器械行业提供创新研发解决方案。公司通过其100多家子公司，打造了一个覆盖全产业链的创新生态，致力于解决全球健康问题，满足患者的医疗需求。截至2024年一季报，泰格医药营业总收入16.6亿元、净利润2.35亿元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/29104140460172.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431046590","title":"泰格医药（300347）4月26日主力资金净买入6334.63万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431046590","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431046590?lang=zh_cn&edition=full","pubTime":"2024-04-29 09:11","pubTimestamp":1714353112,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年4月26日收盘，泰格医药报收于57.7元，上涨8.85%，换手率5.27%，成交量30.45万手，成交额17.05亿元。近5日资金流向一览见下表：泰格医药融资融券信息显示，融资方面，当日融资买入7573.89万元，融资偿还1.51亿元，融资净偿还7544.15万元。泰格医药主营业务：临床试验技术服务和临床试验相关服务及实验室服务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042900002103.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430443252","title":"泰格医药涨8.85%，开源证券三周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2430443252","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430443252?lang=zh_cn&edition=full","pubTime":"2024-04-26 16:24","pubTimestamp":1714119878,"startTime":"0","endTime":"0","summary":"今日泰格医药涨8.85%，收盘报57.7元。2024年3月31日，开源证券研究员余汝意,汪晋发布了对泰格医药的研报《公司信息更新报告：业绩阶段性承压，2024年有望逐步恢复》，该研报对泰格医药给出“买入”评级。此外，西南证券研究员杜向阳，财信证券研究员吴号近期也对该股发布了研报，同样给出“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042600035248.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430954212","title":"港股异动 | 泰格医药(03347)涨超8%领涨CRO概念股 报道称国家层面有望在近期出台生物制造产业行动计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2430954212","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430954212?lang=zh_cn&edition=full","pubTime":"2024-04-26 14:28","pubTimestamp":1714112915,"startTime":"0","endTime":"0","summary":"湘财证券指出，预计国内外医药研发支出将继续增长以及医药研发外包渗透率继续提升将成为CXO产业发展的重要支撑。虽然当前CXO受国内外医药投融资下滑影响业绩承压，但鉴于美联储加息预期逐步减弱，以及经过近两年全球biotech领域估值泡沫的出清，全球生技产业性价比已凸显，创新药投融资环境有望逐步回暖，看好CXO长期向好的短期改善。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1111330.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430939282","title":"泰格医药(03347)上涨5.0%，报32.55元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2430939282","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2430939282?lang=zh_cn&edition=full","pubTime":"2024-04-26 09:39","pubTimestamp":1714095588,"startTime":"0","endTime":"0","summary":"4月26日，泰格医药(03347)盘中上涨5.0%，截至09:39，报32.55元/股，成交1779.77万元。杭州泰格医药科技股份有限公司是一家提供全周期生物医药研发服务的公司，主要为全球制药和医疗器械行业提供创新研发解决方案。公司通过其100多家子公司，打造了一个覆盖全产业链的创新生态，致力于解决全球健康问题，满足患者的医疗需求。截至2024年一季报，泰格医药营业总收入16.6亿元、净利润2.35亿元。4月25日，2024财年一季报归属股东应占溢利2.351亿人民币，同比下降58.65%，基本每股收益0.27人民币。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/26093940422394.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430401797","title":"泰格医药最新公告：一季度净利润2.35亿元 同比下降58.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430401797","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2430401797?lang=zh_cn&edition=full","pubTime":"2024-04-25 20:01","pubTimestamp":1714046496,"startTime":"0","endTime":"0","summary":"泰格医药公布2024年一季度报告，报告期营业收入16.60亿元，同比下降8.00%；归属于上市公司股东的净利润2.35亿元，同比下降58.65%。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042500042164.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2430424406","title":"泰格医药(300347.SZ)发布一季度业绩，净利润2.35亿元，同比减少58.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430424406","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2430424406?lang=zh_cn&edition=full","pubTime":"2024-04-25 19:31","pubTimestamp":1714044678,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药(300347.SZ)发布2024年第一季度报告，该公司于期间实现营业收入16.6亿元，同比减少8%;归属于上市公司股东的净利润2.35亿元，同比减少58.65%;归属于上市公司股东的扣除非经常性损益的净利润3.03亿元，同比减少20.5%;基本每股收益0.27元/股。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1110333.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2430976475","title":"【港股通】泰格医药(03347)首季溢利2.35亿元人民币 同比下降58.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430976475","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2430976475?lang=zh_cn&edition=full","pubTime":"2024-04-25 17:02","pubTimestamp":1714035768,"startTime":"0","endTime":"0","summary":"金吾财讯 | 泰格医药(03347)公布，于2024年第一季度，公司实现归属于上市公司股东的净利润2.35亿元(人民币，下同)，同比下降58.65%；基本每股收益0.27元，同比下降59.09%。期内，录得营业收入16.6亿元，同比下降8%。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/MDI5YWZjNTM0NzAzOGFlZTg0NjQ3Mjg2ZTU5YjgxNDI5NDY5NzkxMw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/MDI5YWZjNTM0NzAzOGFlZTg0NjQ3Mjg2ZTU5YjgxNDI5NDY5NzkxMw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1935808","is_publish_highlight":false,"gpt_icon":0},{"id":"2430475350","title":"《业绩》泰格医药(03347.HK)首季净利润按年跌58.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430475350","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2430475350?lang=zh_cn&edition=full","pubTime":"2024-04-25 17:00","pubTimestamp":1714035600,"startTime":"0","endTime":"0","summary":"泰格医药(03347.HK) 公布，按中国企业会计准则编，截至3月止首季营业收入16.6亿元人民币(下同)，按年下降8%。净利润2.35亿元，按年跌58.65%，每股收益0.27元。(vc/k)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-25 16:25。)过往派息公布日期派息事项派息内容2024/03/28末期业绩普通股息：人民币 0.5682023/10/27第三季业绩无派息2023/08/25中期业绩无派息2023/04/25第一季业绩无派息 AASTOCKS新闻","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20210301160530718_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20210301160530718_s.jpg"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1345118/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2430280473","title":"泰格医药(03347)一季度归母净利润2.35亿元，同比下降58.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2430280473","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2430280473?lang=zh_cn&edition=full","pubTime":"2024-04-25 16:58","pubTimestamp":1714035488,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰格医药(03347)发布2024年第一季度报告，营业收入16.60亿元(人民币，下同)，同比下降8.00%;归属于上市公司股东的净利润2.35亿元，同比下降58.65%;基本每股收益0.27元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1109855.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429168150","title":"泰格医药涨6.76%，开源证券三周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2429168150","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429168150?lang=zh_cn&edition=full","pubTime":"2024-04-23 16:31","pubTimestamp":1713861110,"startTime":"0","endTime":"0","summary":"今日泰格医药涨6.76%，收盘报53.09元。2024年3月31日，开源证券研究员余汝意,汪晋发布了对泰格医药的研报《公司信息更新报告：业绩阶段性承压，2024年有望逐步恢复》，该研报对泰格医药给出“买入”评级。此外，西南证券研究员杜向阳，财信证券研究员吴号近期也对该股发布了研报，同样给出“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042300029955.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429715805","title":"泰格医药(03347)股价上升5.093%，现价港币$30.95","url":"https://stock-news.laohu8.com/highlight/detail?id=2429715805","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429715805?lang=zh_cn&edition=full","pubTime":"2024-04-23 13:42","pubTimestamp":1713850920,"startTime":"0","endTime":"0","summary":"[上升股]泰格医药(03347) 股价在下午01:42比前收市价上升5.093%，现股价为港币$30.95。至目前为止，今日最高价为$30.95，而最低价为$28.7。总成交量为88.03万股，总成交金额为港币$2.621千万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725133914771_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404233062/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2428701415","title":"医药外包概念集体走低 泰格医药(03347)跌超7% 机构称国内医药投融资仍阶段性承压","url":"https://stock-news.laohu8.com/highlight/detail?id=2428701415","media":"金吾财讯","top":-1,"share":"https://www.laohu8.com/m/news/2428701415?lang=zh_cn&edition=full","pubTime":"2024-04-19 10:49","pubTimestamp":1713494972,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药外包概念股持续走低，泰格医药(03347)跌7.62%，康龙化成(03759)跌5.17%，药明生物(02269)、药明康德(02359)均跌超4%。开源证券研报指出，2024年1-3月中国医疗健康产业融资额合计约138.79亿元，同比下滑22.80%；中国医疗健康产业融资事件数在2023Q4阶段性增加后，于2024年回落，2024年1-3月合计约270个，同比下滑14.83%，国内医疗健康领域投融资整体仍处于承压阶段。","market":"sh","thumbnail":"https://static.szfiu.com/news/20210810/OTA2NWNmYzE4MTQyOTUwMjEyNTI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/OTA2NWNmYzE4MTQyOTUwMjEyNTI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1935379","is_publish_highlight":false,"gpt_icon":0},{"id":"2427861662","title":"泰格医药(03347)股价下跌5.148%，现价港币$30.4","url":"https://stock-news.laohu8.com/highlight/detail?id=2427861662","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427861662?lang=zh_cn&edition=full","pubTime":"2024-04-16 10:30","pubTimestamp":1713234600,"startTime":"0","endTime":"0","summary":"[下跌股]泰格医药(03347) 股价在上午10:30比前收市价下跌5.148%，现股价为港币$30.4。至目前为止，今日最高价为$32.05，而最低价为$30.4。总成交量为42.977万股，总成交金额为港币$1.34千万。","market":"hk","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180725131625844_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2404161516/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2427780039","title":"泰格医药(03347.HK)调整回购A股方案   每股上限调整至72元人民币","url":"https://stock-news.laohu8.com/highlight/detail?id=2427780039","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2427780039?lang=zh_cn&edition=full","pubTime":"2024-04-14 19:43","pubTimestamp":1713094980,"startTime":"0","endTime":"0","summary":"泰格医药(03347.HK) 公布，鉴于近期资本市场变化，建议调整回购A股方案，将每股回购价格上限由60元人民币，上调至72元人民币。按回购资金上限10亿人民币估计，回购股数约1,388.88万股。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-12 16:25。)AASTOCKS新闻","market":"us","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20210301160531093_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20210301160531093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1342054/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2426158607","title":"泰格医药(03347)股价上升8.213%，现价港币$33.6","url":"https://stock-news.laohu8.com/highlight/detail?id=2426158607","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2426158607?lang=zh_cn&edition=full","pubTime":"2024-04-09 15:22","pubTimestamp":1712647320,"startTime":"0","endTime":"0","summary":"[上升股]泰格医药(03347) 股价在下午03:22比前收市价上升8.213%，现股价为港币$33.6。至目前为止，今日最高价为$33.6，而最低价为$30.45。总成交量为315.1万股，总成交金额为港币$1.024亿。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2404091996/aamm-all-category","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2012-08-17","address":"浙江省杭州市滨江区西兴街道聚工路19号8幢20层2001-2010室","stockEarnings":[{"period":"1week","weight":0.1134},{"period":"1month","weight":0.1121},{"period":"3month","weight":0.4559},{"period":"6month","weight":-0.1044},{"period":"1year","weight":-0.3445},{"period":"ytd","weight":0.0753}],"companyName":"杭州泰格医药科技股份有限公司","boardCode":"AI0073","perCapita":"--","boardName":"研究和试验发展","registeredCapital":"87241万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":"　　杭州泰格医药科技股份有限公司专注于为新药研发提供临床试验全过程专业服务的合同研究组织(CRO)，为全球医药和医疗器械创新企业提供全面而综合的临床研究解决方案。主要产品为临床试验技术服务、临床试验相关服务及实验室服务等。公司是中国领先的综合生物制药研发服务提供商,且全球的影响力正在不断扩大。根据弗若斯特沙利文报告,按2019年收入及截至2019年年底正在进行的临床试验数量计,公司是中国最大的临床合同研究机构,2019年市场份额为8.4%。根据弗若斯特沙利文报告,公司亦是全球前十强临床合同研究机构中唯一的中国临床合同研究机构。","serverTime":1714612976340,"listedPrice":37.88,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰格医药(300347)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰格医药(300347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰格医药,300347,泰格医药股票,泰格医药股票老虎,泰格医药股票老虎国际,泰格医药行情,泰格医药股票行情,泰格医药股价,泰格医药股市,泰格医药股票价格,泰格医药股票交易,泰格医药股票购买,泰格医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰格医药(300347)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰格医药(300347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}